CDX-622
- Generic Name
- CDX-622
A Phase I Study of CDX-622
- First Posted Date
- 2024-10-21
- Last Posted Date
- 2025-04-17
- Lead Sponsor
- Celldex Therapeutics
- Target Recruit Count
- 56
- Registration Number
- NCT06650761
- Locations
- 🇺🇸
Celerion, Inc., Tempe, Arizona, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath